GW Pharmaceuticals plc announced the appointment of Scott Giacobello as Chief Financial Officer on March 6, 2017. Reporting to GW's Chief Executive Officer Justin Gover, Mr. Giacobello will be based at the Company's U.S. headquarters in Carlsbad, California. Related to this appointment, on March 6, 2017 Adam George, GW's Chief Financial Officer since 2012, became Managing Director UK, a newly-created executive role with broad leadership responsibilities for UK operations, also reporting to Justin Gover.

From 2008 through 2015, Mr. Giacobello held senior level finance positions at Allergan Inc., most recently serving as Vice President of Finance for Global Research & Development. As Managing Director UK, Adam George will be instrumental in ensuring UK operations achieve strategic and operating goals, which include pipeline development, manufacturing scale-up, and European commercialization. Mr. George will continue as Company Secretary and will provide Mr. Giacobello with full support through the CFO transition.